Compare CMRC & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMRC | QSI |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.7M | 165.6M |
| IPO Year | 2020 | 2020 |
| Metric | CMRC | QSI |
|---|---|---|
| Price | $3.56 | $1.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $4.00 | $2.30 |
| AVG Volume (30 Days) | 575.6K | ★ 9.3M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.43 | 28.17 |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $342,349,000.00 | $2,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.21 | $406.32 |
| P/E Ratio | $60.85 | ★ N/A |
| Revenue Growth | ★ 2.83 | N/A |
| 52 Week Low | $1.95 | $0.69 |
| 52 Week High | $5.55 | $2.42 |
| Indicator | CMRC | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 56.63 | 60.23 |
| Support Level | $2.58 | $0.81 |
| Resistance Level | $3.78 | $1.66 |
| Average True Range (ATR) | 0.25 | 0.17 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 48.87 | 59.23 |
Commerce.com Inc is engaged in offering a Software-as-a-Service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which the majority of its revenue is generated from Americas-U.S.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.